Tell us
what you really want
from your fertility clinic abroad…
Complete a 5-minute, anonymous survey to help others find the right clinic abroad, and we'll donate €1 to a fertility society for each submission.

Should you do PGT-A for your donor eggs IVF?

Medically verified
pgt-a-and-egg-donation-cycle
Christos Roukoudis, MD
Gynaecologist & Fertility Specialist
From this event you will find out:
  • What age-related factors may be involved with infertility in females and males?
  • How is PGT-A testing performed?
  • Does PGT-A increase the success rate of IVF?
  • Does PGT-A shorten the time to pregnancy in an egg donation program?
  • Why is PGT-A so controversial?

Table of Contents - Quick Navigation

Is PGT-A recommended in egg donation cycles?

In this live event, Dr Christos Roukoudis, Gynaecologist & Fertility Specialist at IVF-Life Alicante, Spain, has talked about PGT-A and answered a question whether there are any benefits of doing PGT-A for embryos from donor eggs and explained how PGT-A works and when it is recommended.

Dr Christos Roukoudis, first explained that PGT-A (Pre-implantation Genetic Testing for aneuploidies) is a test for chromosome copy numbers that can be used during IVF to help determine the chromosomal status of an embryo from a biopsy of one or more cells. The results can help select an embryo with a normal number of chromosomes, the so-called euploid. But also, it can help us to avoid the ones that have an abnormal number of chromosomes, called aneuploid embryos. They may result in a higher tendency of an IVF failure or a miscarriage.

The number of oocytes starts to decrease after the woman is birth, as shown on the graph. Starting with puberty certain cohort of the oocytes are always recruited, and only one wins the race and becomes dominant. With increasing age, not only does the amount of eggs decreases but also egg quality is decreasing. Those oocytes accompany women during their reproductive life and also are vulnerable to damage in the DNA that they possess. This is one of the reasons why it’s so difficult to have success with own eggs in advanced reproductive age.

Meiosis

Every cell we have has 22 chromosome pairs and depending on the gender, we have an additional XX copy, or if it’s a male, it’s an XY. For a healthy child to be born with a normal number of chromosomes, the eggs available for fertilization must undergo a process of producing or having only one copy of each chromosome. This process is called meiosis, a similar process that occurs in the sperm of the male. The result is that the new life that is created possess 50% of the chromosome of each partner.

With advanced reproductive age, this meiosis process is disturbed and oocytes created have additional copies or don’t have any. This lack of integrity in the oocytes can result in unhealthy embryos that will not implant or lead to an early miscarriage, normally before the 12th week. It can also result in a child with a genetic disease, which happens less often. As shown on the graph, the risk is significantly increased with advancing maternal age, we see that Down syndrome, Edward’s syndrome is more likely to happen compared to a younger age.

PGT-A testing

PGT-A was suggested as a tool to identify those unhealthy embryos. Trisomy 21, Down syndrome and PGT-A testing have become routine methods for IVF to determine whether human embryos are to be clinically utilized or disposed of. The idea is that before an embryo transfer, we want to rule out the aneuploid embryos and only work with the healthy ones to increase the success rates.

Between the late 90s and now, some important events occurred, such as a single polar biopsy, biopsy of the first and the second polar body, the biopsy done on day-3, the cleavage stage, and then at the blastocyst stage when we perform PGT-A.

IVF with PGT-A

First, we have to perform the stimulation to obtain as many oocytes as possible. When the follicles reach a certain size, we do the egg retrieval, once we have the oocytes in the laboratory, the fertilization follows, the embryos will start to develop and on day-5, we’re going to perform PGT-A analysis, and we’re going to freeze them right away because we need to wait for the results almost 3 weeks.

How is the PGT-A test performed? Our biologists take around 6-7 cells from the cells, which are going to form the future placenta called trophectoderm, and we analyse it in our lab. When we finally have the analysis performed by Next Generation Sequencing (NGS), we can see if and in which chromosome pair we have an extra chromosome or possibly a missing chromosome, for example, it’s chromosome 13. As seen on the slide, there is PGT-A analysis done on several embryos, after an IVF cycle, a good amount of embryos was obtained, you can see that many embryos are abnormal, so they’re not suited for a transfer and out of those 5 embryos only 1 is normal.

In the proposed threshold, there are a few classifications like normal, mosaic abnormal, this gives us information about the amount of unhealthy DNA. Normal is if aneuploid DNA in a single biopsy is less than 20%, mosaic is if the aneuploid DNA in this single biopsy is between 20-30% and aneuploid if the aneuploid DNA is more than 80%.

Egg donation

For women with exhausted oocytes reserve, the probability of fulfilling the desire to have a child with their own oocytes is very difficult, so egg donation is the option that can help achieve this goal in the end. It’s a treatment with a very high success rate, the pregnancy rates are around 75% with the first attempt at our clinic (IVF-Life). The reason for that is that egg donors are very young and they have the best oocyte quality. We do some tests before the treatment and before selecting a donor, a mapping of their own chromosomes that allow us to see if they have a higher tendency of producing unhealthy embryos. This factor allows us to have very high success rates, there is the success rate of the time spawn between 20- 25 years old

One of the publications from 2007 from the UK shows how the live birth rate decreases with the advanced maternal age of the eggs and therefore conclude how important healthy eggs are for success. We can see how extremely difficult it is to have success with your own eggs between the age of 44-46.

Regarding PGT-A testing in another publication from 2016 performed in the US, we can see that in certain groups PGT-A testing is beneficial. Patients of advanced reproductive age and a certain collective may benefit from PGT-A.
We can see that at a young age, the age of the donors is between 20-25, we have no significant advantage when we perform PGT-A testing, it’s rather the same when PGT-A testing is performed, you see that the live birth rate is high, so women have the success rate of the donors.

PGT-A – why is it controversial?

PGT-A testing is rather a matter of debate. For example, mosaicism is where a certain amount of DNA in the cell is not okay, it’s frequently found in pre-implantation stage embryos, and it seems that it represents a normal physiological finding at those stages. Chromosomally abnormal embryos may self-correct downstream, this explains the persistence of chromosomally abnormal cells in the placentas of healthy babies.

Another reason why it is criticized is that the average 5-7 cells of the trophectoderm biopsy that we perform cannot define the state of an embryo for 100%. Something that we are also not 100% sure about is the impact of damage that is caused by a biopsy, human embryos are sensitive to manipulation and biopsy.

Several case reports are showing that embryos tested as mosaic but in some cases also as aneuploid resulted in healthy babies. We have a high number of false-positive rates, which means that this test can show us that the embryo is unhealthy or not suited for a transfer, but in reality, it’s suited for a transfer. Consequently, one must conclude that many false-positive embryos are either not used in a treatment maintaining clear preservation or even get discarded, therefore, it’s also an ethical problem.

There is also a STAR trial, which stands for a Single Embryo Transfer of aneuploid embryo, it was a multicentric study including 4 countries and many centres. It was one of the largest studies undertaken, and it included 650 subjects. They were randomized, the primary outcome of the study was the ongoing pregnancy rate after the 20th week of pregnancy. It was found that the ongoing survival rate was not a lot higher regardless if PGT-A testing was performed or not. However, as shown on the slide, a certain patient group would benefit out of it, it was the group of 35 to 40 because the ongoing live birth rate was much higher. When PGT-A testing was performed at a younger age, so we’re talking about the egg donor, it didn’t make such a big difference at all.

Conclusions

It’s very important to see the big picture. PGT-A testing offers benefits when it is used properly, however, we mustn’t forget that not all couples will benefit from it. The patient should have an increased reproductive age and produce multiple embryos.

We must take into account that every time it must be an individual decision. All the factors of the couple matter, for example, if the couple faced multiple implantation failures, miscarriages, in such cases, patients could benefit from PGT-A testing. Patients who undergo egg donation need to look at the live birth rate of the donor, so they have the live birth rate of a 20-25-year-old, PGT-A testing doesn’t make a big difference, and it could be most likely counterproductive in the end. It’s because of false-positive results, and the ethical dilemma is also a matter of debate. One exception could be where the Karyotype of the husband or some findings could lead to a higher tendency of producing unhealthy embryos.

Related reading:

Should you do PGT-A for your donor eggs IVF? | FAQ

What are your thoughts on donor egg using PGT-A versus MitoScore and or male factor?

As I said before, egg donation gives us a very high success rate on its own, so there is no significant benefit out of PGT-A testing with egg donors. 

If we have a male factor, it’s not always possible to recognize a microdeletion in the karyotype. Some minor abnormalities that seem to be minor can lead to a higher tendency of producing unhealthy sperm/ eggs. In such situations, yes, PGT-A testing could help us a bit. 

What about increased male age as an indication for PGT-A?

Not really because sperm come out of the fabric every three months, so if the karyotype is okay, it’s not a strict indication to do PGT-A testing because of higher male age. There is no data about it.

What are your thoughts on CRISPR, and before PGT-A?

For me, it would not make any sense to do it prior. I would like to have a Karyotype before, this is enough for me. It’s also significant to make an individual decision to see what the couple has been through, what they have done before, everything.

Is it better to get a donor egg having the same blood type as myself?

There are plenty of investigations in this field where they say the blood group doesn’t play a role. The only reason is if you want to keep it a secret because technically, your children could find out through the blood group if their blood group is the same as yours and your husband. For the success of the treatment, it doesn’t play a role at all.

So far, we have had 5 failed transfers with one egg and 1 miscarriage. We recently tried a donor egg with 1 excellent and good blastocyst, which failed. If we try egg donation again, would you use PGT-A testing to check for implantation failure, or the donor round was just bad luck. We have a 5-year-old child conceived naturally.

This is a case where I must look into details. I must look, for example, if there’s any other reason for the miscarriages, the genetic integrity of an embryo is a very important reason, but we also have other reasons, such as the womb, the uterus, immunological deficiencies, celiac disease. There are many things, so first, we need to do our homework and see what happened. I don’t think that PGT-A testing would be a big game-changer in your situation, from what I see. You have already proved that you can conceive, you can have a baby and have a normal pregnancy. The only thing is that with PGT-A, we could have success with the first attempt, the cumulative rate is the same regardless if I have 3 embryos or 2 embryos, the cumulative rate is the same, but with PGT-A testing, we could have success a bit sooner.

As I told you before, this is a matter of debate, in the end, so I would first have a look into your history, you can feel free to send your file to me, and I can have a look, and I can tell you if I would do anything different. Don’t compare your own trials with the egg donation because most likely your transfers were done in a more advanced reproductive age, but I would be happy to give you a second opinion.

Any relation between egg donation failure and celiac disease in terms of success?

Yes, there is a relation there because if somebody has celiac disease, it means that someone has antibodies against glutamine, there’s the Anti-transglutaminase antibody and the Anti-Gliadine antibody.

If somebody has celiac disease, they have those antibodies in their blood, and those antibodies could attack the ongoing pregnancy, regardless if you do egg donation or an IVF treatment with your own eggs, celiac disease could play a role. It’s very easy to test for these antibodies, and the solution is much easier, you need to take the gluten out from your diet.

If the egg donor is young, for example 25 years old, is there still a chance that embryos could be abnormal? If so, how often does that happen?

In biology, there is never a situation where something is 100% or 0%. Mitotic and meiotic errors can occur even in embryos from younger eggs.

There are self-repairing mechanisms that work better in younger embryos than in older ones. Therefore, while errors can occur, they are much less common in younger eggs.

From our experience, when we performed PGT testing in embryos derived from donor eggs, we tested around 20 embryos and found only one aneuploid embryo. This means the risk exists but is relatively low.

There are also interesting studies performed on mice and rats to examine the self-repairing potential of blastocysts. Researchers injected a chemical compound into part of the inner cell mass that genetically damaged those cells.

When 50% of the inner cell mass was affected and the embryos were transferred, all offspring were born healthy with no genetic problems. Scientists concluded that in early development, these cells are embryonic stem cells with the same genetic information. When half of them are damaged, the healthy cells can divide more and compensate for the damaged ones.

Even when 75% of those cells were affected, around 50% of the offspring were still genetically normal.

Although these studies were performed on animals, mammals share similar biological mechanisms. This suggests that embryos may have a strong capacity for self-correction.

This is why biology is complex. Even if we identify abnormal cells, it does not always mean the embryo cannot develop into a healthy child. However, this does not mean we recommend transferring aneuploid embryos. It simply shows that biological processes are not always fully predictable.

Another important point is that large datasets have not demonstrated higher pregnancy rates for couples who used PGT-A testing with donor eggs compared with those who did not.

When would you recommend PGT-A testing for embryos created with donor eggs?

One important factor is the male partner’s fertility.

If a couple comes to the clinic because the woman cannot use her own eggs and donor eggs are required, we then evaluate the sperm quality. If there is severe male factor infertility—for example, severe oligo-teratozoospermia, where only a small portion of sperm have normal morphology—PGT-A testing may be considered.

Another factor is male age, because DNA fragmentation in sperm increases with age, and genetic errors may occur more frequently.

In cases with strong male factor infertility, we are more open to discussing PGT-A testing even when donor eggs are used.

This does not include cases of inherited genetic diseases. In such situations, different types of testing are used, such as PGT-M for monogenic diseases or PGT-SR for structural chromosomal abnormalities.

What testing is performed before embryo transfer for a patient aged 40 with PCOS and endometriosis?

I am not a gynaecologist, but from my experience, I know that stimulation in patients with PCOS and endometriosis can be challenging.

Sometimes stimulation results in very few usable eggs, while in other cases, after adjusting the protocol, many eggs can be retrieved. However, egg quality may still be an issue, especially at age 40.

For example, we may retrieve five or six eggs and obtain one or two blastocysts. When only one blastocyst is available, it becomes difficult to decide whether PGT-A testing should be performed. In such cases, we present the information to the patient and allow them to decide.

If donor eggs are used, embryos are generally not tested unless PGT-A is specifically performed. Without PGT testing, embryos are evaluated primarily by:

  • Morphological assessment

  • Time-lapse morphokinetic analysis (if available)

These methods help embryologists choose the embryo with the best developmental parameters.

There are also supportive transfer media such as EmbryoGlue, which contains hyaluronic acid and may slightly increase the chances of implantation.

Ultimately, success also depends on factors such as endometrial receptivity and the quality of the embryo transfer procedure.

How do you check whether an embryo is healthy in embryo adoption?

Embryo adoption typically means embryos created from donor eggs and donor sperm.

There are also legal considerations. In our clinic, embryos can only be created if a patient has signed informed consent for their creation. If additional embryos remain, they may later be donated to another couple.

PGT-A testing in embryo adoption raises ethical and legal questions because someone must consent to the genetic testing. Donors are usually not asked to provide such consent.

From a biological perspective, there is also the question of whether performing an invasive biopsy is justified when most embryos created from donor eggs and donor sperm are expected to be chromosomally normal.

Nevertheless, some clinics offer this approach, and we are considering studying it further in order to collect data and evaluate outcomes.

Does EmbryoGlue increase success rates for frozen embryo transfers?

Studies and our clinic’s own data suggest that embryo glue may increase success rates slightly.

For example, if the success rate in frozen cycles is around 40%, the use of embryo glue may increase it to approximately 42%. This is a small improvement, but it may still be beneficial.

At our clinic, we combine several supportive techniques, such as:

  • sperm selection methods

  • time-lapse embryo incubation

  • specialised transfer media like embryo glue

Each technique may contribute a small increase in success rates, and together they may slightly improve the overall outcome.

Can donor eggs be used during perimenopause?

Yes. Donor egg treatment is often recommended for patients whose own ovarian function is declining or no longer active. In such cases, donor eggs can provide a realistic opportunity to achieve pregnancy.

In the Czech Republic, can patients see photos or personal details of sperm donors?

In the Czech Republic, donor identity is legally anonymous.

Patients cannot receive identifying information such as the donor’s name or location. However, clinics can provide non-identifying information such as:

  • hair color

  • eye color

  • height and weight

  • skin tone

  • blood group

Donors are also tested for genetic diseases. If a patient carries a genetic condition, the clinic can select a donor who does not carry the same mutation to avoid passing the condition to the child.

Would you recommend PGT-A if donor sperm is used with a patient’s own frozen eggs?

The most important factor is the age of the eggs at the time they were frozen.

If the eggs were frozen before age 32–35, the situation is similar to donor eggs, and PGT-A is generally not necessary.

If the eggs were frozen after age 35, the risk of chromosomal abnormalities increases, and PGT-A may be worth considering.

The number of embryos also matters. If only one or two blastocysts are available, testing may not be beneficial. If six blastocysts are available, testing may help identify which embryos have the highest potential and shorten the time to pregnancy.

What genetic testing options exist besides PGT-A?

There are three main types of genetic testing:

PGT-A (Preimplantation Genetic Testing for Aneuploidy)
This test checks whether embryos have the correct number of chromosomes.

PGT-SR (Preimplantation Genetic Testing for Structural Rearrangements)
This is used when one partner carries a structural chromosomal abnormality such as a translocation.

PGT-M (Preimplantation Genetic Testing for Monogenic Diseases)
This test is used when there is a known inherited disease, such as cystic fibrosis or certain cancer-related genes.

In PGT-M testing, embryos are screened both for the specific genetic mutation and for normal chromosome numbers.

To summarize, should patients perform PGT-A testing when using donor eggs?

My personal view is that I am not generally a strong supporter of routine PGT-A testing for embryos created from donor eggs.

If the donor is younger than about 32 years old, I usually would not recommend it. If the donor is older than 32, or if there is significant male factor infertility, it may be reasonable to discuss it.

The decision should always be individualised. Every couple and every treatment cycle is different, and the best approach depends on factors such as:

  • medical history

  • sperm quality

  • egg quality

  • ovarian reserve

  • hormone levels

  • patient preferences

Fertility Knowledgebase - Related Events

Related Fertility Questions - Answered by Various Experts

How much does PGT A PGS testing cost?

Maria José Mendiola, MD, MSc in Human Genetics, MSc in Science Communication, ObGyn
Gynaecologist

+ 1 more answers

Read More »

How many embryos should you PGT-A / PGS test?

Dimitra Christopikou, Clinical Laboratory Geneticist
Geneticist

Read More »

What happens after PGS / PGT-A testing?

Maria José Mendiola, MD, MSc in Human Genetics, MSc in Science Communication, ObGyn
Gynaecologist

+ 3 more answers

Read More »

On what day are embryos biopsied for PGT-A?

Raúl Olivares, MD
Gynaecologist

Read More »

Can I use PGT-A / PGS for gender selection?

Nurit Winkler,
Gynaecologist

+ 1 more answers

Read More »

Can you do a fresh embryo transfer with PGT-A / PGS?

Raúl Olivares, MD
Gynaecologist

+ 1 more answers

Read More »